How the 1934 Geneva Debates Sealed Turkey's Hashish Export Ban

September 17, 2026

Photo via Unsplash.

Picture a committee room in Geneva sometime in 1934, wood-paneled and thick with cigarette smoke, delegates from a dozen countries hunched over translated transcripts of the League of Nations Opium Advisory Committee. An Egyptian delegate named El Guindy stands to make a claim: that hashish is responsible for somewhere between 30 and 60 percent of insanity cases in Egypt. He offers no study, no citation, no data set. Nobody in the room objects. The claim simply sits there, unchallenged, and within a few years it has helped justify a wave of prohibition commitments stretching from Athens to Ankara to Cairo.

It's tempting to treat Turkey's hashish export ban as something that happened in that one Geneva session -- a single dramatic vote sealing the fate of esrar production across Anatolia. That's not quite what occurred. The ban was the endpoint of a process that started nearly a decade earlier, with the 1925 Geneva Convention, and was locked into Turkish domestic law a full year before the 1934 debates even began. Geneva didn't invent Turkey's prohibition; it applied pressure to finish what was already underway and to extend it regionally.

What makes this story worth revisiting isn't just the legal mechanics. It's the way one country's enforcement failure -- Egypt's inability to stop hashish smuggling across its own borders -- got translated into a shared regional obligation, with Turkey, Greece, Cyprus, Syria and others all asked to police cultivation and trade on Egypt's behalf. The paper trail runs from a quiet 1925 sub-committee clause through a Turkish law published in the Official Gazette in 1933, to a single unsupported statistic that somehow became the evidentiary backbone of international cannabis policy for the following five years.

The 1925 Convention Planted the Seed

Photo via Unsplash.

The mechanism that eventually squeezed Turkey's hashish trade wasn't built for that purpose at all. It was bolted onto opium diplomacy almost as an afterthought. The Second Geneva Opium Convention, signed 19 February 1925, was primarily concerned with morphine, heroin and cocaine -- the pharmaceutical-grade narcotics that worried European governments watching addiction rates climb after the First World War. Cannabis got folded in through a clause requiring signatories to prohibit the export of Indian hemp resin -- hashish, esrar, chiras, djamba, the regional names varied but the substance didn't -- to any country that had already banned its domestic use.

That clause came out of a sub-committee whose membership reads like a list of the era's major hemp-producing and hemp-transiting states: Belgium, Egypt, France, the British Empire, India, Siam, Turkey and Uruguay. Turkey wasn't a bystander dragged into this later. It sat at the table from the beginning, participating in the very drafting process that would eventually be used to pressure it.

What's striking, looking back at the record, is how little debate the cannabis provision actually generated. The convention as a whole was adopted on 14 February 1925 after considerable wrangling over opium quotas and manufacturing limits -- the stuff governments actually cared about. Cannabis rode in on the coattails of that fight, addressed almost in passing, without the kind of dedicated scientific or medical hearing that its later consequences would seem to demand. There was no extended argument about dosage, no toxicology testimony, no delegate standing up to ask what evidence existed for treating hashish resin the same way the convention treated raw opium derivatives. It simply went into the text.

That's the part worth sitting with. A provision that would eventually justify agricultural bans, crop destruction mandates and criminal penalties across multiple countries entered international law almost by default, attached to a treaty built around a different substance entirely. Turkey's later domestic law and its later capitulation in Geneva both trace back to this quiet, under-discussed clause from 1925 -- not to any fresh finding about cannabis itself.

Turkey Writes Its Own Law First

Photo by cin . via Unsplash.

By the time Egyptian delegates were pressing the Opium Advisory Committee in 1934, Turkey had already done the work. Law No. 2313 on the Control of Narcotic Drugs passed the Grand National Assembly on 12 June 1933 and was published in the Official Gazette twelve days later, on 24 June. It wasn't a minor regulatory tweak. Article 3 banned outright the farming of Cannabis Indica for the production of hashish -- esrar, in Turkish usage -- and criminalized the full chain of activity around it: preparing it, importing it, exporting it, selling it. Article 23 went further, mandating the physical destruction of any Cannabis Indica plants found growing, regardless of who was cultivating them or why. Penalties ran from one to six months' imprisonment for violators, a modest sentence by later drug-war standards but a clear signal of state intent.

This sequencing matters. When Turkish delegates walked into the 1934 Geneva sessions and faced mounting pressure to formally commit to international hashish controls, they weren't negotiating from a blank slate. They had a concrete domestic statute already on the books, already enforced, already published for a year. That gave Turkey leverage of a particular kind -- the ability to present itself as a country already in compliance with the spirit of what Geneva wanted, rather than a holdout being dragged toward reform.

The 1933 law didn't emerge in a vacuum, either. It followed a significant diplomatic disclosure eighteen months earlier: in January 1932, Prime Minister Ismet Inonu told Eric Einar Ekstrand, the League's opium affairs chief, that Turkey was shutting down three morphine and heroin factories operating on its territory. That admission signaled a broader shift in how Ankara viewed its narcotics sector -- from an economic asset worth protecting to a liability worth cleaning up, at least on paper, ahead of closer international scrutiny. Cannabis Indica cultivation got swept into that same reformist push a year later.

El Guindy's Case Against Hashish

Photo via Unsplash.

The 19th session of the Opium Advisory Committee in 1934 is where the hashish question stopped being a background clause and became the main event. Egyptian delegate El Guindy argued for extending the kind of controls an earlier international opium convention had applied to opium and its derivatives to cover Indian hemp as well -- meaning cannabis and its preparations would be restricted to medical and scientific use only, full stop. His target was specific: the raw resin, charas, harvested from the flowering tops of female cannabis plants, along with everything made from it -- hashish, chira, esrar, diamba, whatever regional name applied.

To make his case, El Guindy offered a statistic that would echo through the following decade of policy discussion: that somewhere between 30 and 60 percent of insanity cases in Egypt could be attributed to hashish use. It's worth pausing on how wide that range is -- a 30-point spread suggests the number wasn't drawn from careful clinical accounting so much as impression and estimate. No supporting study accompanied the claim. No data set, no hospital records, no methodology. Just the assertion, delivered to a room of delegates deciding international drug policy.

What happened next -- or rather, what didn't happen -- is the part of this story that deserves the most scrutiny. No delegate in that committee room contradicted El Guindy. None of the national representatives, and none of the medical or scientific advisors attached to various national delegations, spoke up against it. Given that this was precisely the kind of forum meant to weigh evidence before recommending binding international controls, the silence is remarkable. A claim with the power to reshape agricultural policy and criminal law across multiple countries passed without a single challenge.

The 1934 session didn't resolve the matter outright, though. Rather than adopting sweeping new controls on the spot, the committee referred the question to a subcommittee for further study -- an acknowledgment, perhaps, that the evidentiary basis wasn't quite there yet, even as the political momentum toward prohibition kept building regardless.

Why Turkey, Greece and Egypt Bore the Pressure

The timeline traces the path to Turkey's 1933 hashish law, from the 1925 Geneva Convention and a 1932 diplomatic visit by Ekstrand to Ankara, through the law's passage and publication in mid-1933, culminating in its review at the 1934 Geneva session.

None of this happened because of a hashish crisis inside Turkey. It happened because Egypt couldn't stop hashish from crossing its own borders. El Guindy's push at Geneva was, at its core, a response to years of failed interdiction efforts along Egypt's coastline and desert frontiers, where resin produced elsewhere kept finding its way in despite domestic bans and customs enforcement. Egypt had already prohibited cannabis cultivation and trade within its own territory, and that domestic ban had reshaped enforcement patterns across the eastern Mediterranean -- but a ban on one side of a border does little good if supply keeps arriving from the other side.

So the ask in Geneva wasn't really about Turkey's internal drug policy at all. It was a request -- backed by the weight of an international committee -- for a whole set of countries to help Egypt solve its own smuggling problem. Greece, Cyprus, Turkey, Sudan, Syria, Lebanon and Palestine were all drawn into this framework, each asked to restrict cultivation and trade within its own territory specifically to shore up Egypt's borders. It's an unusual dynamic when you look at it plainly: one country's enforcement failure becoming the justification for a region-wide set of agricultural and criminal prohibitions in half a dozen neighboring states.

Turkey's geography made it an obvious target for this kind of request. Anatolia had long been both a producer of cannabis resin and a transit corridor for hashish moving toward Mediterranean and Middle Eastern markets. A country in that position was always going to draw attention once the international conversation turned toward supply-side controls rather than just domestic consumption bans.

Turkish diplomat Sevket Fuat's stated intention to have Turkey accede to both the 1925 and 1931 Geneva conventions marked a genuine reversal from the country's earlier diplomatic posture. For years, Turkish delegations had worked to protect the country's opium export sector -- a legitimate and economically significant trade -- from overly aggressive international restriction. Bending on hashish, a comparatively smaller piece of the narcotics economy, let Turkey demonstrate cooperative intent on drug control broadly while continuing to defend the parts of its narcotics trade that actually mattered to its treasury.

The Subcommittee That Studied Cannabis for Five Years

Photo via Unsplash.

Here's the detail that undercuts the whole affair: after the 1934 session generated enough momentum to push Turkey and its neighbors toward hashish prohibition, the League didn't move straight to a final, settled policy. It launched a sub-committee that spent five years, from 1934 to 1939, studying the very question that had already effectively been decided in practice. Countries were tightening their laws and destroying crops while the League's own experts were still trying to establish what, exactly, the evidence showed.

Part of what drove that extended review was a growing recognition within the League that cannabis wasn't staying confined to the colonial and Middle Eastern territories where European officials had mostly encountered it. Reports of use reaching European populations directly shifted the tenor of the discussion -- this was no longer a problem the League could treat as someone else's regional concern, manageable through export controls on distant hemp-producing regions.

The testimony that fed the sub-committee's five-year study came overwhelmingly from medical officers stationed across the Middle East and North Africa -- colonial and mandate-territory physicians reporting what they observed in local clinical settings, without the kind of controlled methodology that would satisfy later standards of drug research. Among the more frequently cited sources was Dr. Bouquet, whose studies conducted in Tunisia became something close to a reference text for the subcommittee's deliberations, cited repeatedly as the closest thing to systematic evidence the League had on hand.

Look at the timeline honestly and the sequence is almost backwards from how policy is supposed to work. The claim was made in 1934. The pressure on Turkey, Greece and their neighbors took hold immediately afterward. The actual scientific review -- five years of it -- came after the political and legal consequences were already in motion, not before. The League spent the back half of the 1930s trying to catch up evidentially to a decision the international community had already made politically.

Strip away the treaty language and committee minutes, and what's left looks less like a public-health intervention and more like a diplomatic transaction. Turkey didn't ban hashish exports because Turkish physicians had identified a domestic crisis demanding urgent action. It banned them because absorbing part of Egypt's smuggling problem was the price of good standing among the community of nations negotiating international drug control -- a reasonable trade for a country simultaneously trying to protect its far more lucrative opium export trade from similar restriction.

The unchallenged insanity statistic from that 1934 committee room deserves to be remembered specifically, not as a historical curiosity but as a warning about how thin the evidentiary floor can be under decisions that end up governing agricultural policy and criminal law for generations. A 30-to-60 percent range, offered without a study behind it, sat in the official record of an international body for years while a five-year subcommittee tried, after the fact, to build the evidence that should have come first.

That pattern didn't stay confined to 1934. Versions of it recur throughout the twentieth century's drug policy history -- assertions treated as settled fact ahead of the research that might have tested them, regional enforcement failures generalized into international obligations, domestic law hardened into treaty commitment before the underlying science existed to justify it. Anyone reading today's cannabis debates, in Turkey or anywhere else, is still standing on legal foundations poured in rooms like that one in Geneva -- foundations worth examining rather than simply assuming were built to spec.